Thursday, May 4, 2023 Daily Archives

Dutch gov puts vaccine maker Intravacc up for sale

by

Those looking to buy Bilthoven, The Netherlands-based vaccine contract manufacturer Intravacc have until 2 June to contact the Dutch State. Founded in 2013, Intravacc is a 200-person strong contract development and manufacturing organization (CDMO) with a 2,000 square-meter site located in the Utrecht Science Park, Bilthoven with two GMP facilities offering production up to 200 L. The state-owned vaccine maker has transferred its technology for vaccines including polio, measles, DTP, Hib and influenza. The firm played a part in an…

May 4, 2023

J&J forks out $245m to develop CAR-T therapies

by

Johnson & Johnson has partnered with Cellular Biomedicine Group to advance, produce, and commercialize CAR-T cell therapies for the treatment of B-cell malignancies. The deal sees Chinese company Cellular Biomedicine Group (CBMG) receive an upfront payment of $245 million from J&J’s subsidiary Janssen Biotech. In return, CBMG will grant Janssen access to develop and commercialize its CAR-T assets, except in Greater China. Moreover, Janssen said it will bolster its portfolio in B-cell malignancies. The investigational CD20-directed autologous chimeric antigen receptor…

May 4, 2023

BioCina awarded $3.3m grant to bolster mRNA capabilities

by

The Australian CDMO has been awarded a $3.3 million grant by the Australian Government’s National Health and Medical Research Council (NHMRC) to support the demand for mRNA. The contract development manufacturing organization (CDMO) said the grant awarded under the government’s Medical Research Future Fund (MRFF) will fund activities with its industry partners to advance technologies for the production of messenger RNA (mRNA) vaccines. In September 2020, Bridgewest Australia Holdings, a subsidiary of private investment firm Bridgewest Group, entered the biologics…

May 4, 2023